Bone Biologics Corporation (BBLG) Stock

Bone Biologics Corporation (BBLG) is a Healthcare stock trading at $0.61 (as of 2026-08-20), with a market capitalization of $1.67M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

I can’t prepare a compliant description because the company’s SEC 10‑K “Business” (Item 1) text wasn’t provided. Please paste the Item 1 Business section so I can base the 1–2 sentence summary on the authoritative source.

Valuation — source: SEC EDGAR (first-party)
Price$0.61
Market Cap$1.67M
Price / Book0.42
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.07B
Net Margin-0.2%
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderMORGAN STANLEY ($60763.00)
Institutional Holders Tracked7
Company
SectorHealthcare
IndustryMedical Equipment
CEOJeffrey Frelick
Employees2
CountryUS
IPO Date2021-10-13

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)
  • HeartSciences Inc. (HSCS)
  • ENvue Medical, Inc. (FEED)
  • CollPlant Biotechnologies Ltd. (CLGN)
  • Catheter Precision, Inc. (VTAK)
  • Sonoma Pharmaceuticals, Inc. (SNOA)
  • Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD)
  • INVO Fertility, Inc. (IVF)
BBLG earnings history · BBLG institutional & insider holders · BBLG KPIs & operating metrics · BBLG financials · BBLG investor presentations & press releases · BBLG SEC filings · BBLG peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.